1 Mease P, 34 : 1415-1425, 2007
2 Wittmann J, "microRNAs in rheumatoid arthritis:midget RNAs with a giant impact" 70 (70): 92-96, 2011
3 Sampaio-Barros PD, "Undifferentiated spondyloarthropathies: a 2-year follow-up study" 20 : 201-206, 2001
4 Wolfe F, "The natural history of rheumatoid arthritis" 44 : 13-22, 1996
5 Van der Heide A, "The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial" 124 : 699-707, 1996
6 Rudwaleit M, "The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection" 68 : 777-783, 2009
7 Dougados M, "The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy" 34 : 1218-1227, 1991
8 Zeidler H, "The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general:the spondyloarthritis concept in progress" 70 : 1-3, 2011
9 Arnett FC, "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis" 31 : 315-324, 1988
10 Wolfe F, "The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity" 62 : 600-610, 2010
1 Mease P, 34 : 1415-1425, 2007
2 Wittmann J, "microRNAs in rheumatoid arthritis:midget RNAs with a giant impact" 70 (70): 92-96, 2011
3 Sampaio-Barros PD, "Undifferentiated spondyloarthropathies: a 2-year follow-up study" 20 : 201-206, 2001
4 Wolfe F, "The natural history of rheumatoid arthritis" 44 : 13-22, 1996
5 Van der Heide A, "The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial" 124 : 699-707, 1996
6 Rudwaleit M, "The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection" 68 : 777-783, 2009
7 Dougados M, "The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy" 34 : 1218-1227, 1991
8 Zeidler H, "The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general:the spondyloarthritis concept in progress" 70 : 1-3, 2011
9 Arnett FC, "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis" 31 : 315-324, 1988
10 Wolfe F, "The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity" 62 : 600-610, 2010
11 Wolfe F, "The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee" 33 : 160-172, 1990
12 Mitchell DM, "Survival, prognosis, and causes of death in rheumatoid arthritis" 29 : 706-714, 1986
13 Bennett AN, "Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years" 58 : 3413-3418, 2008
14 Doan T, "Rheumatoid arthritis: an overview of new and emerging therapies" 45 : 751-762, 2005
15 Aletaha D, "Rheumatoid arthritis classification criteria: an American College of Rheumatology /European League Against Rheumatism collaborative initiative" 62 : 569-581, 2010
16 Mau W, "Results of a 10-year follow-up" 15 : 1109-1114, 1988
17 Tilleman K, "Proteomics in rheumatology" 5 : 755-759, 2008
18 Bennett PH, "Population studies of the rheumatic diseases" 477-478, 1968
19 Visser K, "Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature" 8 : 1094-1099, 2009
20 Smolen JS, "New therapies for the treatment of rheumatoid arthritis" 370 : 1861-1874, 2007
21 Scott DL, "Long- term outcome of treating rheumatoid arthritis: results after 20 years" 1 : 1108-1111, 1987
22 BukhariMA, "Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study" 48 : 46-53, 2003
23 Fitzcharles MA, "Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals" 42 : 263-267, 2003
24 de Vries RR, "Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?" 70 (70): 51-54, 2011
25 Gracely RH, "Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia" 46 : 1333-1343, 2002
26 Mease P, "Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment" 75 : 6-21, 2005
27 Mease P, "Fibromyalgia syndrome module at OMERACT 9:domain construct" 36 : 2318-2329, 2009
28 Van der Linden S, "Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria" 27 : 361-368, 1984
29 Van Dongen H, "Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial" 56 : 424-432, 2007
30 Oostveen J, "Early detection ofsacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study" 26 : 1953-1958, 1999
31 Amor B, "Criteres de classification des spondylarthropathies" 57 : 85-89, 1990
32 Choy EH, "Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome" 36 : 2330-2334, 2009
33 Buskila D, "Awareness of diagnostic and clinical features of fibromyalgia among family physicians" 14 : 238-241, 1997
34 Khan MA, "A wider spectrum of spondyloarthropathies" 20 : 107-113, 1990
35 Arnold LM, "A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder" 50 : 2974-2984, 2004
36 Ropes MW, "1958revision of diagnostic criteria for rheumatoid arthritis" 9 : 175-176, 1958